Drug Discovery World

SEPTEMBER 29, 2022

During a 2021 webinar on optimising assay development for hit identification, a survey asked over 50 drug discovery scientists, “Which goal is the highest priority when developing a drug discovery assay?”. The company has the resources to complete the project in-house or it could outsource it to CROs.

Small Molecule 130

Small Molecule Assay Development DNA Biochemical Assays 130

Drug Discovery World

APRIL 3, 2023

Also, the large, immunogenic nature of antibodies and protein ligands as therapeutic molecules means our partners are looking for alternative solutions that offer reduced immunogenicity and improved tissue penetration properties. Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies.

Science 130

Science Molecular Biology Therapies Disease 130

Elrig

APRIL 29, 2024

My role involved generating and characterizing complex proteins critical for biological assay development, hit discovery, and structural biology. There, I supported AI-enabled DD efforts in their small molecule portfolio. big pharma or startups/spin off? Where do you enjoy more to work? What pro/cons?

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59